U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H23NO4.ClH
Molecular Weight 377.862
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N-(3-BUTENYL)NOROXYMORPHONE HYDROCHLORIDE

SMILES

Cl.[H][C@@]12OC3=C4C(C[C@@]5([H])N(CCC=C)CC[C@@]14[C@@]5(O)CCC2=O)=CC=C3O

InChI

InChIKey=UMLGCEOOYPDDJJ-ITLPAZOVSA-N
InChI=1S/C20H23NO4.ClH/c1-2-3-9-21-10-8-19-16-12-4-5-13(22)17(16)25-18(19)14(23)6-7-20(19,24)15(21)11-12;/h2,4-5,15,18,22,24H,1,3,6-11H2;1H/t15-,18+,19+,20-;/m1./s1

HIDE SMILES / InChI

Approval Year

Name Type Language
N-(3-BUTENYL)NOROXYMORPHONE HYDROCHLORIDE
Common Name English
NALTREXONE RELATED COMPOUND A [USP-RS]
Common Name English
NALTREXONE RELATED COMPOUND A [USP IMPURITY]
Common Name English
NIH-10458
Common Name English
MORPHINAN-6-ONE, 17-(3-BUTENYL)-4,5-EPOXY-3,14-DIHYDROXY-, HYDROCHLORIDE, (5.ALPHA.)-
Systematic Name English
17-(BUT-3-EN-1-YL)-4,5-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE HYDROCHLORIDE
Systematic Name English
N-(3-BUTENYL)NOROXYMORPHONE HYDROCHLORIDE [USP IMPURITY]
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID70747238
Created by admin on Sat Dec 16 10:33:04 GMT 2023 , Edited by admin on Sat Dec 16 10:33:04 GMT 2023
PRIMARY
FDA UNII
0M3EP0YZ2R
Created by admin on Sat Dec 16 10:33:04 GMT 2023 , Edited by admin on Sat Dec 16 10:33:04 GMT 2023
PRIMARY
RS_ITEM_NUM
1453526
Created by admin on Sat Dec 16 10:33:04 GMT 2023 , Edited by admin on Sat Dec 16 10:33:04 GMT 2023
PRIMARY
PUBCHEM
71314313
Created by admin on Sat Dec 16 10:33:04 GMT 2023 , Edited by admin on Sat Dec 16 10:33:04 GMT 2023
PRIMARY
CAS
131670-05-8
Created by admin on Sat Dec 16 10:33:04 GMT 2023 , Edited by admin on Sat Dec 16 10:33:04 GMT 2023
PRIMARY